BIOS Capital Management, LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| OPUS GENETICS INC | 3,683,429 | 3,683,429 | 0 | 7,403,692 | 16,759,602 | 31.70% | +9,355,910 |
| REIN THERAPEUTICS INC | 1,690,751 | 1,982,375 | +291,624 | 1,961,271 | 2,577,088 | 4.87% | +615,817 |
| IN8BIO INC | 253,417 | 167,805 | -85,612 | 592,996 | 248,351 | 0.47% | -344,645 |
| LANTERN PHARMA INC | 1,009,507 | 864,435 | -145,072 | 3,058,806 | 1,184,276 | 2.24% | -1,874,530 |
| COGNITION THERAPEUTICS INC | 6,000,000 | 6,000,000 | 0 | 8,100,001 | 4,560,000 | 8.63% | -3,540,001 |
| ACTUATE THERAPEUTICS INC | 10,049,996 | 10,049,996 | 0 | 61,505,976 | 27,536,989 | 52.09% | -33,968,987 |